ZA200610628B - Composition for diagnosing and treating circulatory system diseases - Google Patents

Composition for diagnosing and treating circulatory system diseases

Info

Publication number
ZA200610628B
ZA200610628B ZA200610628A ZA200610628A ZA200610628B ZA 200610628 B ZA200610628 B ZA 200610628B ZA 200610628 A ZA200610628 A ZA 200610628A ZA 200610628 A ZA200610628 A ZA 200610628A ZA 200610628 B ZA200610628 B ZA 200610628B
Authority
ZA
South Africa
Prior art keywords
diagnosing
composition
circulatory system
system diseases
treating circulatory
Prior art date
Application number
ZA200610628A
Inventor
Pieter Theodore Ernst
Original Assignee
Ernst Johanna Catarina
Ernst Pieter Benjamin
Ernest Hugo Alexander
Ernest Maxwell Theodore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2005907104A external-priority patent/AU2005907104A0/en
Application filed by Ernst Johanna Catarina, Ernst Pieter Benjamin, Ernest Hugo Alexander, Ernest Maxwell Theodore filed Critical Ernst Johanna Catarina
Publication of ZA200610628B publication Critical patent/ZA200610628B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
ZA200610628A 2005-12-19 2006-12-15 Composition for diagnosing and treating circulatory system diseases ZA200610628B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2005907104A AU2005907104A0 (en) 2005-12-19 Circulatory System Disease Diagnosis and Treatment

Publications (1)

Publication Number Publication Date
ZA200610628B true ZA200610628B (en) 2008-06-25

Family

ID=38121999

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200610628A ZA200610628B (en) 2005-12-19 2006-12-15 Composition for diagnosing and treating circulatory system diseases

Country Status (2)

Country Link
WO (1) WO2007072147A2 (en)
ZA (1) ZA200610628B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9101537B2 (en) 2008-07-25 2015-08-11 Reven Pharmaceuticals, Inc. Compositions and methods for the prevention and treatment of cardiovascular diseases
CN103327986B (en) 2010-07-22 2018-05-25 雷文制药有限公司 Comprising the treatment using magnetic dipole stabilizing solutions or improve disease and enhance the method for performance
CN110292639A (en) * 2011-01-06 2019-10-01 C·洛维尔·帕森斯 The method of composition of the manufacture comprising local anesthetic, heparan and buffer
CN115245143A (en) * 2022-07-06 2022-10-28 上海市中西医结合医院 Construction method of artery occlusive disease animal model

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1231907A2 (en) * 1999-11-15 2002-08-21 Hanamaraddi T. Gangal Dextrose and insulin fluid formulation for intravenous infusion
US6284293B1 (en) * 2000-04-12 2001-09-04 Jeffery J. Crandall Method for generating oxygenated water
AU2096002A (en) * 2000-12-08 2002-06-18 Pieter Theo Ernst Therapeutic treatment
JP4653945B2 (en) * 2003-10-24 2011-03-16 ミズ株式会社 Pharmacologically functional water and its use

Also Published As

Publication number Publication date
WO2007072147A3 (en) 2007-11-01
WO2007072147A2 (en) 2007-06-28

Similar Documents

Publication Publication Date Title
IL185256A0 (en) Method and composition for treating peripheral vascular diseases
HK1216080A1 (en) Compositions and methods for treating or preventing oxalate-related disease
IL233634A0 (en) Methods, compositions, and kits for the treatment of medical conditions
EP1737482A4 (en) Compositions and methods for treating diseases
EP1945754A4 (en) Compositions and methods for treating and diagnosing cancer
HK1179275A1 (en) Compositions and methods for diagnosing and treating cancer
GB0503380D0 (en) Tissue treatment system
HK1115328A1 (en) Composition for treating skin lesions
EP1950209A4 (en) Agent for treatment of circulatory failure
EP2069391A4 (en) Compositions and methods for treating or preventing ophthalmic disease
ZA200810199B (en) Rinse-off therapeutic agents for treating skin
ZA200610628B (en) Composition for diagnosing and treating circulatory system diseases
GB0620695D0 (en) Composition and methods for the treatment of nurdegenerative disease
GB0503382D0 (en) Tissue treatment system
EP1909836A4 (en) Methods for treating and detecting beta-cell disease
IL185900A0 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1951914A4 (en) Diagnostic and therapeutic methods and agents
IL191887A0 (en) Method for the diagnosis and treatment of cardiovascular diseases
GB0505203D0 (en) Skin composition treatment
GB0519334D0 (en) Method and composition for treating skin
ZA200706159B (en) Compositions and methods for the diagnosis and treatment of tumor
EP1841443A4 (en) Method and system for treating heart failure
GB0507963D0 (en) Composition and method for treating disease
GB0522732D0 (en) Composition and method for treating disease
AU2005907104A0 (en) Circulatory System Disease Diagnosis and Treatment